DexCom Non-GAAP EPS of $0.34 beats by $0.11, revenue of $871.3M beats by $30.35M
DexCom press release  (NASDAQ:DXCM): Q2  Non-GAAP EPS of $0.34  beats by $0.11.
Revenue of $871.3M (+25.2% Y/Y)  beats by $30.35M.
U.S.Â revenue growth of 21% and international revenue growth of 38% on a reported basis. International revenue growth was 40% on an organic1Â basis.

2023 Outlook:Â Revenue of approximately $3.500 - 3.550 billion (20-22% growth)
Non-GAAP Gross Profit Margin of approximately 63%
Non-GAAP Operating Margin of approximately 17%
Adjusted EBITDA Margin of approximately 26.5%.
Shares +4.36%.